ZeClinics

ZeClinics is a Barcelona-based CRO that has established itself as a zebrafish expert, providing customized in vivo research services to pharmaceutical, biotechnology, and agrochemical clients globally. Its core value proposition lies in using genetically engineered zebrafish to model human diseases and screen compounds, offering a faster, more cost-effective, and ethical alternative to early mammalian testing. The company operates through three main service lines: ZeTox for toxicology, ZeGenesis for custom model generation, and ZeEfficacy for drug efficacy screening. With a client base spanning academia and industry, ZeClinics is positioned at the intersection of the growing demand for translational animal models and the global push to reduce mammalian testing.

A zebrafish-based preclinical research platform utilizing CRISPR/Cas9 for custom genetic disease modeling, automated phenotypic screening for efficacy, and toxicology testing. It leverages the organism's high fecundity, optical transparency, and genetic homology to humans for cost-effective, high-throughput in vivo studies.

ZeClinics competes within the broad preclinical CRO market, which includes giants like Charles River Laboratories and Labcorp. Its direct niche competitors are other zebrafish-specialized CROs (e.g., Biobide, also in Spain) and companies developing alternative non-mammalian models (e.g., nematode, fly) or in vitro systems (organ-on-a-chip). Differentiation is based on deep zebrafish expertise, CRISPR capabilities, and a strong client partnership model.